Clinical Trial

Long-Term Safety and Efficacy of HSK39004 Inhalation Suspension in COPD

Name: Long-Term Safety and Efficacy of HSK39004 Inhalation Suspension in COPD — clinical trial record (NCT07634367)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

This clinical trial evaluates the long-term safety and efficacy of 3 mg HSK39004 Inhalation Suspension administered twice daily for 52 weeks in subjects aged 40 to 80 years with moderate-to-severe stable chronic obstructive pulmonary disease (COPD).

Trial Details

NCT Number	NCT07634367
Lead Sponsor	Haisco Pharmaceutical Group Co., Ltd.
Conditions	COPD (Chronic Obstructive Pulmonary Disease)
Enrollment	300 participants
Start Date	2026-07-10
Primary Completion	2027-12-24 (estimated)
Study Completion	2027-12-24 (estimated)
Updated on ClinicalTrials.gov	2026-06-08